IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Spruce Street Capital LP

Q1 2026 Holdings

Filed 2026-05-14 | 28 holdings | $415.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Relmada Therapeutics Inc(RLMD)COM75955J402$43.0M6,262,11410.3%
Kiniksa Pharmaceuticals I(KNSA)ORD SHS CL AG52694109$36.6M761,0638.8%
LB Pharmaceuticals Inc(LBRX)COM SHS50180M108$33.6M1,376,1598.1%
Dianthus Therapeutics in(DNTH)COM252828108$31.3M373,2747.5%
Relay Therapeutics Inc(RLAY)COM75943R102$29.7M2,984,1257.1%
Alto Neuroscience Inc(ANRO)COM SHS02157Q109$29.1M1,325,2107.0%
Centessa Pharmaceuticals(CNTA)SPONSORED ADS152309100$19.5M489,8494.7%
Savara Inc(SVRA)COM805111101$18.5M3,383,1754.4%
Kalvista Pharmaceuticals(KALV)COM483497103$18.1M897,6814.3%
Vaxcyte Inc(PCVX)COM92243G108$14.3M245,7093.4%
Enliven Therapeutics Inc(ELVN)COM29337E102$12.9M329,0063.1%
Surrozen Inc COM New(SRZN)COM NEW86889P208$12.6M432,0403.0%
Enanta Pharmaceuticals I(ENTA)COM29251M106$11.8M932,5982.8%
Alkermes PLC(ALKS)SHSG01767105$11.2M317,9922.7%
Perspective Therapeutics(CATX)COM NEW46489V302$11.0M2,627,1072.6%
Minerva Neuroscienc(NERV)COM NEW603380205$10.0M1,655,5002.4%
Century Therapeutics(IPSC)COM15673T100$9.2M4,059,0542.2%
Alumis Inc(ALMS)COM022307102$8.6M392,5742.1%
SAB Biotherapeutics in(SABS)COM NEW78397T202$8.4M2,198,5022.0%
Erasca Inc(ERAS)COM29479A108$6.8M422,5431.6%
Inhibikase Therapeuti(IKT)COM NEW45719W205$6.0M3,581,6031.4%
Maze Therapeutics Inc(MAZE)COM578784100$6.0M200,0001.4%
An2 Therapeutics Inc(ANTX)COM037326105$5.6M1,661,0731.3%
Lexeo Therapeutics Inc(LXEO)COM52886X107$5.3M928,5931.3%
Helix Acquisition Corp IIIUSD CL A ORD SHSG4444S107$5.1M500,0001.2%
Alector Inc(ALEC)COM014442107$4.5M2,101,0681.1%
Leonabio Inc(LONA)COM04746L203$3.8M393,7010.9%
Corvus Pharmaceuticals I(CRVS)COM221015100$3.4M231,5850.8%